Evidence-Based Supplement Research

Bifidobacterium breve M-16V and Improved Gut Microbiota Composition

Doses used in studies

CFU/day: 20 billion (median 20 billion, IQR 20 billion–20 billion) — 1 study

Time to effect

Median: 2.8 months · IQR 2.8 months–2.8 months · Range 2.8 months–2.8 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityNo significant difference
The frequency of adverse events was not different between the groups.
from: Imaging and Microorganism Analyses of the Effects of Oral Bifidobacterium breve Intake on

1 of 1 paper

Imaging and Microorganism Analyses of the Effects of Oral Bifidobacterium breve Intake on Facial Skin in Females: A Randomized, Double-Blind, Placebo-Controlled Study.